IFNG and melanoma: Our findings of impaired NK cell degranulation and IFNγ production in STS patients align with previous studies in other malignancies, such as acute myeloid leukemia and various solid tumors, but contrast with observations in melanoma patients, where degranulation is often preserved [26,27,28].